" class="no-js "lang="en-US"> Parkinson's Disease Archives - Medtech Alert
Friday, June 09, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease

The University of Oxford and Selvita, one of the largest contract research organizations in Europe, […]

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease

HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]

Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting

Verana Health, a digital health company elevating quality in real-world data (RWD), has announced it’s […]

AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson's Disease

Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary […]

BlueRock Therapeutics to use Rune Labs' Clinical Trial Platform to Better Characterize Parkinson's Disease State in Cell Therapy Trials

Rune Labs, a precision neurology software and data platform company, today announced a partnership with […]

Celltrion and LISCure Biosciences Announce Strategic Collaboration to Develop Novel Microbiome Treatment for Parkinson's Disease

LISCure Biosciences, a clinical-stage biotech developing advanced microbiome technology with precision targets, announced a multi-year […]

Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine

Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]

MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson's Disease

MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset […]

  1. Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
  2. Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
  3. Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
  4. Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
  5. Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more